BridgeBio have significantly improved the development of the new treatment for ATTR-CM, employing the compound. Early patient data suggests significant improvements for patients suffering by the debilitating illness. The emphasis underscores the company’s focus to treating critical patient demands in a heart disease space. Attruby: Brid… Read More